Cohort Study of Definitive Chemoradiotherapy for Esophageal or Esophagogastric Junction Cancer
Latest Information Update: 27 Sep 2023
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 06 Apr 2021 New trial record